Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Wearable Pregnancy Devices Market size was valued at USD 23.16 billion in 2024 and is expected to reach USD 174.38 billion by 2037, registering around 16.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of wearable pregnancy devices is assessed at USD 26.47 billion.
The growth of the market can be attributed to the growing awareness of the importance of fitness among expectant mothers and a healthier lifestyle during pregnancy. According to the World Health Organization (WHO), hypertensive-related illnesses during pregnancy accounted for 14% of all maternal deaths globally. Also, as per the data published by the Preeclampsia Foundation, preeclampsia and related hypertensive disorders of pregnancy impacted 5-8% of all births in the United States, and the rate had been increased by 25% in the last two decades and is further known to be the leading cause of maternal and infant illness and death. Pregnant women can use a "wearable" tool to identify if they have or are at risk of developing a condition that could lead to adverse health problems for them or their developing fetus. Thus, the growing number of pregnant women with complications is expected to lead to an increase in demand for wearable pregnancy devices.
Wearable Pregnancy Devices Sector: Growth Drivers and Challenges
Growth Drivers
- Growing Understanding of the Importance of Fitness During Pregnancy
- Rising Cases of Pregnancy Complications
Challenges
- People’s Lack of Product Knowledge
- High Speculation Regarding the Emission of Harmful Radiations from these Gadgets
Wearable Pregnancy Devices Market: Key Insights
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
16.8% |
|
Base Year Market Size (2024) |
USD 23.16 billion |
|
Forecast Year Market Size (2037) |
USD 174.38 billion |
|
Regional Scope |
|
Wearable Pregnancy Devices Segmentation
The market is segmented by product category into health tracking devices, real time contraction tracking devices, heart rate monitoring devices, blood pressure monitoring, and others, out of which, the health tracking devices segment is expected to account for the largest share of the global wearable pregnancy devices market owing to rising awareness about the importance of fitness during pregnancy and an increase in cases of complications in expectant mothers, accompanied by an increase in the number of early adoptions and improved healthcare infrastructure.
Our in-depth analysis of the global wearable pregnancy devices market includes the following segments:
|
By Product Category |
|
|
By Distribution Channel |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Wearable Pregnancy Devices Industry - Regional Synopsis
North America Market Statistics
North America industry is poised to dominate majority revenue share by 2037, on the back of rising awareness about the importance of fitness during pregnancy and an increase in cases of complications in expectant mothers. As per the data released by U.S. Centers for Disease Control and Prevention National Center for Health Statistics (CDC-NCHS), in the year 2020, the maternal mortality rate in the United States was 23.8 deaths per 100,000 live births.
On the other hand, as a result of the increased number of early adoptions of new technology and improved healthcare infrastructure in this region, Asia-Pacific is predicted to develop considerably in the wearable pregnancy devices market, during the forecast period.
Companies Dominating the Wearable Pregnancy Devices Landscape
- Abbott
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Medtronic
- NUVO Inc.
- Apple Inc.
- Bloomlife, Inc.
- Brainlab AG
- Koninklijke Philips N.V.
- Bellabeat, Inc.
- Aparito Limited
- Varian Medical Systems, Inc. (Siemens Healthineers)
Recent Developments
-
June 12, 2020: Koninklijke Philips N.V. has launched an obstetric monitoring solution to assist health care professionals and expectant mothers during the COVID-19 outbreak.
-
March 30, 2020: NUVO Inc. announced that it has received FDA clearance to market INVU, a prescription-initiated, protocol-driven remote monitoring platform that provides fetal and maternal heart rate measurements via a wireless, self-administered INVU sensor band.
Author Credits: Radhika Pawar
- Report ID: 470
- Published Date: Dec 23, 2024
- Report Format: PDF, PPT
